BioSpace News Archive

Business

Cerus Corporation Reports Third Quarter 2017 Results

At September 30, 2017, the Company had cash, cash equivalents and short-term investments of $59.6 million compared to $71.6 million at December 31, 2016.

November 2, 2017

·

11 min read

Drug Development

Intersect ENT Announces a Pivotal Study Publication of PROPEL Contour Steroid Releasing Sinus Implant

The study met its primary efficacy endpoint, demonstrating a previously reported statistically significant 65% relative reduction in the need for post-operative interventions.

November 2, 2017

·

6 min read

Biotech Beach

Puma Biotechnology Secures $100 Million Term Loan From Silicon Valley Bank and Oxford Finance

Puma received gross proceeds of $50 million from the first tranche of the credit facility upon closing on October 31 and intends to use the funds for general corporate purposes and to further support NERLYNX commercial initiatives.

November 2, 2017

·

5 min read

Business

PerkinElmer Announces Financial Results for the Third Quarter of 2017

GAAP revenue in the third quarter of 2017 was $554.3 million, as compared to $514.5 million in the third quarter of 2016.

November 2, 2017

·

32 min read

Bio NC

TransEnterix to Feature Senhance Surgical System at AAGL: Advancing Minimally Invasive Gynecology Worldwide

The congress will be held November 12-16, 2017 in the Washington, DC area at the Gaylord National Resort and Convention Center at National Harbor.

November 2, 2017

·

3 min read

Biotech Beach

Human Factors Research Presented at DTM 2017 Demonstrates Ease of Use and Effectiveness of Computer-Based Training for Touchscreen Insulin Pump With Automated Insulin Delivery Feature

The study demonstrated a 99 percent success rate among study participants who performed a series of critical tasks using the PLGS system after initial training.

November 2, 2017

·

4 min read

Drug Development

Dimerix Presents Detailed Subgroup Analysis From DMX-200 Phase IIa Trial in Chronic Kidney Disease Showing Compelling Efficacy Signals in Diabetic Nephropathy Patients

Five of the 6 patient responder sub-group (83%) had a primary diagnosis of diabetic nephropathy and 1 of the 6 responders (17%) had a primary diagnosis of IgA nephropathy.

November 2, 2017

·

6 min read

Business

Invacare Announces Departure of Chief Financial Officer

Invacare today announced the resignation of Sr. VP and CFO Robert K. Gudbranson, who will be leaving the company to pursue a new opportunity, effective November 26, 2017

November 2, 2017

·

4 min read

Drug Development

Cristal Therapeutics Progresses Nanomedicine CriPec®-docetaxel to Phase 1b Development in Patients With Solid Tumours

Cristal Therapeutics announced today that it has begun a Phase Ib clinical program of its lead nanomedicine candidate CriPec-docetaxel in patients with solid tumours.

November 2, 2017

·

1 min read

OptiBiotix Release: New Research On Synthetic Prebiotics Presented At US Microbiome R&D Event

Professor Bob Rastall, Professor of Food Biotechnology at the University of Reading, has presented research on an exciting, emerging area of microbiome modulation at the 5th Microbiome R&D and Business Collaboration Forum in San Diego.

November 2, 2017

·

3 min read